About Technology Issues FAQ

Links

Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years

Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.